Problems in human rabies post-exposure prophylaxis management

Travel Medicine and Infectious Disease

Volumn 5, Issue 3, 2007, Pages 189-193

  Tepsumethanon, Saowaluck ^a   Tepsumethanon, Veera ^a   Tantawichien, Thanphet ^a   Suwansrinon, Kanitta ^a   Wilde, Henry ^a  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

Human rabies exposure; Rabies; Rabies post exposure prophylaxis

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BITE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG SAFETY; ENDEMIC DISEASE; EXPERIENCE; FOLLOW UP; HEALTH CARE FINANCING; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RABIES; SERUM SICKNESS; TREATMENT REFUSAL; WORLD HEALTH ORGANIZATION; WOUND INFECTION;

ANIMALS; BITES AND STINGS; DOGS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RABIES; RABIES VACCINES; RABIES VIRUS; THAILAND; VACCINATION;

EID: 34247177465     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2006.07.001     Document Type: Article

References (12)

1. World Health Organization. Expert Committee on Rabies, Report no. 824. WHO, Geneva, 1992.
2. Centers for Disease Control and Prevention. Human Rabies Prevention-United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1999; 48: 1-21.
3. In: Jackson A.C., and Wunner W.H. (Eds). Rabies (2002), Academic Press, Amsterdam
4. Tantawichien T., Benjavongkulchai M., Wilde H., et al. Value of skin testing for predicting reaction to equine rabies immune globulin. Clin Infect Dis 21 (1995) 660-662
5. Khawplod P., Wilde H., Chomchey P., et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 14 5 (1996) 389-391
6. Khawplod P., Wilde H., Sirikawin S., et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90 day booster injection. Vaccine 12 (2006) 3084-3086
7. Khawplod P., Wilde H., Yenmuang W., et al. Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with Semple or suckling mouse brain vaccine. Vaccine 14 (1996) 1549-1552
8. Jaijaroensup W., Tantawichien T., Khawplod P., et al. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis 28 (1999) 913-914
9. Smith J.S., Fishbein D.B., Rupprecht C.E., and Clark K. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 324 4 (1991) 205-211
10. Chutivongse S., Wilde H., Benjavongkulchai M., et al. Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants. Clin Infect Dis 20 (1995) 818-820
11. Wilde H., and Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am J Trop Med Hyg 42 2 (1990) 175-178
12. Tepsumethanon V., Lumlertdacha B., Mitmoonpitak C., et al. Fluorescent antibody test for rabies: prospective study of 8987 brains. Clin Infect Dis 25 (1997) 1459-1461